Antiretroviral Nephrotoxicities

Research output: Contribution to journalArticle

Abstract

With the introduction of combination antiretroviral therapy, there have been substantial declines in both morbidity and mortality associated with human immunodeficiency virus (HIV)-1 infection. However, data increasingly indicate that HIV-1-infected individuals are faced with accelerated rates of chronic diseases that afflict the general population such as diabetes mellitus, hypertension, and dyslipidemia, as well as cardiovascular, liver, and kidney diseases. Furthermore, this population is exposed to a variety of adverse effects from long-term use of antiretroviral medications, which may cause clinically important renal toxicities. However, it often is challenging to distinguish antiretroviral-related renal toxicity from either direct effects of HIV-1 on the kidney or from a multitude of non-HIV-related kidney diseases. A timely and coordinated effort by the HIV primary provider and a nephrologist is likely to facilitate the evaluation of HIV-1-infected patients with new kidney problems.

Original languageEnglish (US)
Pages (from-to)563-575
Number of pages13
JournalSeminars in Nephrology
Volume28
Issue number6
DOIs
StatePublished - Nov 2008

Fingerprint

HIV-1
Kidney
Kidney Diseases
Virus Diseases
Dyslipidemias
Population
Liver Diseases
Diabetes Mellitus
Chronic Disease
Cardiovascular Diseases
HIV
Hypertension
Viruses
Morbidity
Mortality
Therapeutics

Keywords

  • acute renal failure
  • antiretroviral therapy
  • Fanconi
  • Kidney
  • nephrolithiasis
  • nephrotoxicity

ASJC Scopus subject areas

  • Nephrology

Cite this

Antiretroviral Nephrotoxicities. / Atta, Mohamed; Deray, Gilbert; Lucas, Gregory M.

In: Seminars in Nephrology, Vol. 28, No. 6, 11.2008, p. 563-575.

Research output: Contribution to journalArticle

Atta, Mohamed ; Deray, Gilbert ; Lucas, Gregory M. / Antiretroviral Nephrotoxicities. In: Seminars in Nephrology. 2008 ; Vol. 28, No. 6. pp. 563-575.
@article{2f1cd538ef464ae29d735a76775e0715,
title = "Antiretroviral Nephrotoxicities",
abstract = "With the introduction of combination antiretroviral therapy, there have been substantial declines in both morbidity and mortality associated with human immunodeficiency virus (HIV)-1 infection. However, data increasingly indicate that HIV-1-infected individuals are faced with accelerated rates of chronic diseases that afflict the general population such as diabetes mellitus, hypertension, and dyslipidemia, as well as cardiovascular, liver, and kidney diseases. Furthermore, this population is exposed to a variety of adverse effects from long-term use of antiretroviral medications, which may cause clinically important renal toxicities. However, it often is challenging to distinguish antiretroviral-related renal toxicity from either direct effects of HIV-1 on the kidney or from a multitude of non-HIV-related kidney diseases. A timely and coordinated effort by the HIV primary provider and a nephrologist is likely to facilitate the evaluation of HIV-1-infected patients with new kidney problems.",
keywords = "acute renal failure, antiretroviral therapy, Fanconi, Kidney, nephrolithiasis, nephrotoxicity",
author = "Mohamed Atta and Gilbert Deray and Lucas, {Gregory M}",
year = "2008",
month = "11",
doi = "10.1016/j.semnephrol.2008.08.009",
language = "English (US)",
volume = "28",
pages = "563--575",
journal = "Seminars in Nephrology",
issn = "0270-9295",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Antiretroviral Nephrotoxicities

AU - Atta, Mohamed

AU - Deray, Gilbert

AU - Lucas, Gregory M

PY - 2008/11

Y1 - 2008/11

N2 - With the introduction of combination antiretroviral therapy, there have been substantial declines in both morbidity and mortality associated with human immunodeficiency virus (HIV)-1 infection. However, data increasingly indicate that HIV-1-infected individuals are faced with accelerated rates of chronic diseases that afflict the general population such as diabetes mellitus, hypertension, and dyslipidemia, as well as cardiovascular, liver, and kidney diseases. Furthermore, this population is exposed to a variety of adverse effects from long-term use of antiretroviral medications, which may cause clinically important renal toxicities. However, it often is challenging to distinguish antiretroviral-related renal toxicity from either direct effects of HIV-1 on the kidney or from a multitude of non-HIV-related kidney diseases. A timely and coordinated effort by the HIV primary provider and a nephrologist is likely to facilitate the evaluation of HIV-1-infected patients with new kidney problems.

AB - With the introduction of combination antiretroviral therapy, there have been substantial declines in both morbidity and mortality associated with human immunodeficiency virus (HIV)-1 infection. However, data increasingly indicate that HIV-1-infected individuals are faced with accelerated rates of chronic diseases that afflict the general population such as diabetes mellitus, hypertension, and dyslipidemia, as well as cardiovascular, liver, and kidney diseases. Furthermore, this population is exposed to a variety of adverse effects from long-term use of antiretroviral medications, which may cause clinically important renal toxicities. However, it often is challenging to distinguish antiretroviral-related renal toxicity from either direct effects of HIV-1 on the kidney or from a multitude of non-HIV-related kidney diseases. A timely and coordinated effort by the HIV primary provider and a nephrologist is likely to facilitate the evaluation of HIV-1-infected patients with new kidney problems.

KW - acute renal failure

KW - antiretroviral therapy

KW - Fanconi

KW - Kidney

KW - nephrolithiasis

KW - nephrotoxicity

UR - http://www.scopus.com/inward/record.url?scp=55649102973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55649102973&partnerID=8YFLogxK

U2 - 10.1016/j.semnephrol.2008.08.009

DO - 10.1016/j.semnephrol.2008.08.009

M3 - Article

C2 - 19013327

AN - SCOPUS:55649102973

VL - 28

SP - 563

EP - 575

JO - Seminars in Nephrology

JF - Seminars in Nephrology

SN - 0270-9295

IS - 6

ER -